Bevacizumab biosimilar (Celltrion) | Interleukin Related interleukin-related.com

Product Name :
Bevacizumab biosimilar (Celltrion)

Search keywords :
Bevacizumab

drugId :
null

Target Vo:
Vascular endothelial growth factor A

Target Vo Short Name :
VEGFA

Moa_Name:
Vascular endothelial growth factor A inhibitors

First Approval Country :
EU

First Approval Date Filter:
2022

Origin Company_Name :
Celltrion Inc

Active Company_Name :
Celltrion Healthcare Hungary Kft

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ERCC1 (YP6027) Mouse mAb Purity & Documentation
Anti-Mouse IFNAR1 Antibody (MAR1-5A3) Data Sheet
Paxillin Antibody: Paxillin Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 65 kDa, targeting to Paxillin. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts